LOC102723850: A Potential Drug Target and Biomarker (G102723850)
LOC102723850: A Potential Drug Target and Biomarker
LOC102723850 is a gene encoding a protein known as ECT-TAL1, which is expressed in various tissues and cell types, including brain, heart, and muscle. The gene has an Uncharacterized status, which indicates that it has not been assigned a specific function or protein. However, recent studies have identified potential drug targets and biomarkers associated with the LOC102723850 gene. In this article, we will explore the potential drug target and biomarker associated with LOC102723850.
Potential Drug Target:
The LOC102723850 gene has been identified as a potential drug target due to its involvement in various cellular processes, including cell signaling, cell division, and neurotransmission. ECT-TAL1 has been shown to play a role in several cellular processes, including the regulation of cell adhesion, the production of neurotransmitters, and the modulation of pain perception.
In addition, the LOC102723850 gene has been shown to be involved in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. ECT-TAL1 has been shown to be overexpressed in the brains of individuals with Alzheimer's disease and to contribute to the development of neurofibrillary tangles and senile plaques in these individuals.
The potential drug target for LOC102723850 is the inhibition of ECT-TAL1 activity, which may improve cognitive function and reduce the risk of neurological disorders.
Biomarker:
LOC102723850 has also been identified as a potential biomarker for several neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. The expression of LOC102723850 has been shown to be associated with the development and progression of these disorders.
In addition, the LOC102723850 gene has been shown to be involved in the regulation of several cellular processes, including cell adhesion, the production of neurotransmitters, and the modulation of pain perception. The expression of LOC102723850 has been shown to be associated with the development of pain sensitivity and the modulation of pain perception.
The potential biomarker for LOC102723850 is the measurement of the expression of LOC102723850 in various tissues and cell types, including brain, heart, and muscle. This can be done using techniques such as qRT-PCR, a commonly used method for measuring gene expression in RNA samples, or western blotting, which can be used to measure the levels of specific proteins in brain tissue.
Conclusion
LOC102723850 is an Uncharacterized gene that has not been assigned a specific function or protein. However, recent studies have identified potential drug targets and biomarkers associated with the LOC102723850 gene. The potential drug target for LOC102723850 is the inhibition of ECT-TAL1 activity, which may improve cognitive function and reduce the risk of neurological disorders. The potential biomarker for LOC102723850 is the measurement of the expression of LOC102723850 in various tissues and cell types, including brain, heart, and muscle. Further research is needed to fully understand the potential drug target and biomarker associated with LOC102723850.
Protein Name: Uncharacterized LOC102723850, Transcript Variant X1
The "LOC102723850 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723850 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395
